In this role, Dr. Spector will lead ICON’s global consulting and drug development services and will also be responsible for ICON’s business process improvement and analytics capabilities.Dr Spector is an expert in clinical development and brings to ICON over 25 years of experience in managing global drug and medical device development programmes. He joins ICON from Allergan Pharmaceuticals, where he was Senior Vice President of Global Development Operations, responsible for staff in 11 global research centres which contributed to approvals in over 51 countries.